Consumer Genomics

1D - Consumer Genomics: Direct or Indirect, Does It Really Matter?
(Attendance CEU 1.5)

Monday, October 9
10:15 AM - 11:45 AM

With the rise, fall, and re-emergence of consumer genomic testing we are seeing the field break into two segments. One which is initiated and driven by the consumer, and another that can be initiated by either the consumer or their physician, but must be ordered by the physician. Through independent talks and a panel discussion we would like to have an open conversation with the audience about the near future of consumer genomic testing, be it ordered at home or with the help of a physician.

Learning Objectives:

Matthew J. Ferber

Assistant Professor of Laboratory Medicine and Pathology
Mayo Clinic

Matthew Ferber, PhD, is an assistant professor and consultant in the Department of Laboratory Medicine and Pathology serving as a Co-Director for the Clinical Molecular Genetics Laboratory and the founder of the Clinical Genome Sequencing Laboratory at Mayo. He has worked very closely with Mayo Clinic's Center For Individualized Medicine over the years serving as a founding member of the Clinomics program, which created the Individualized Medicine Clinic and Mayo's Diagnostic Odyssey Services.

Presentation(s):

Send Email for Matthew Ferber

Teresa Kruisselbrink

Supervisory Genetic Counselor
Mayo Clinic Center for Individualized Medicine

Teresa Kruisselbrink is Genetic Counselor Supervisor in the Mayo Clinic Center for Individualized Medicine. She began her career in 1997 at Mayo Clinic by establishing the role of the laboratory based genetic counselor in Molecular Genetics, Biochemical Genetics, Cytogenetics and Maternal Serum Screening. She has provided genetic counseling in Medical Genetics, neurology, obstetrics, cardiology and outreach clinics. Ms. Kruisselbrink contributes to numerous educational programs including Mayo Medical School, Graduate School, and fellowship and residency programs in the laboratory and clinical environments. She is also actively involved in mentoring high school and college students wishing to pursue a career in genetic counseling. Teresa received her B.S. in Molecular, Cellular, Developmental Biology and Genetics and M.S. in Genetic Counseling from the University of Minnesota. She is an Instructor of Laboratory Medicine and Pathology.

Presentation(s):

Send Email for Teresa Kruisselbrink

Robert C. Green

Director, Genomes2People
Harvard Medical School

Robert C. Green, MD, MPH, of Harvard Medical School, Brigham and Women's Hospital, and the Broad Institute, is a medical geneticist and physician-scientist who directs the Genomes2People Research Program in translational genomics and health outcomes.

Dr. Green is accelerating the implementation of genomics into medicine by conducting empirical research on associated medical, behavioral and economic outcomes. He leads the first randomized trials of clinical genome sequencing in adults (the MedSeq Project) and newborns (the BabySeq Project), and was recently awarded the first research project on clinical sequencing of personnel in the US Armed Forces.
He has been continuously funded by NIH for over 26 years and has published over 300 scientific papers. In 2014, he won the Coriell Prize for Scientific Achievement in Personalized Medicine. His work has been repeatedly highlighted on NBC Nightly News, the Today Show, CNBC, the New York Times, the Wall Street Journal, Time Magazine, New Scientist, FastCompany and Buzzfeed. He has forged research collaborations with Genomics England, Illumina, 23andMe and Google; advises a number of biotechnology and genomics companies, and has co-founded an investor-backed telemedicine start-up company, Genome Medical, Inc. He has been invited to speak at the World Science Festival, Forbes Healthcare Summit, Exponential Medicine, and South By Southwest.

Dr. Green graduated from Amherst College and the University of Virginia School of Medicine, and earned a Masters of Public Health in epidemiology from Emory University School of Public Health. He obtained specialty training at Harvard Medical School residencies and fellowships, and is board certified in both neurology and medical genetics.

Presentation(s):

Send Email for Robert Green

David Bick

MD
Hudson Alpha

David Bick, MD, is the Chief Medical Officer and a faculty investigator at the HudsonAlpha Institute for Biotechnology. Dr. Bick also serves as the Medical Director of the Smith Family Clinic for Genomic Medicine, LLC located on the campus of HudsonAlpha Institute for Biotechnology and as a laboratory director in the HudsonAlpha Clinical Services Laboratory, LLC.

He came to HudsonAlpha from the Medical College of Wisconsin where he was Professor in the Department of Pediatrics and the Department of Obstetrics & Gynecology. At the Medical College of Wisconsin he was the Director of the Clinical Sequencing Laboratory, Director of the Advanced Genomics Laboratory at Children’s Hospital of Wisconsin, Medical Director of the Genetics Clinic at Children’s Hospital of Wisconsin, and Chief of the Division of Genetics in the Department of Pediatrics at Medical College of Wisconsin.

Dr. Bick received his medical degree from George Washington University School of Medicine in 1981 and completed his residency in Pediatrics at Yale-New Haven Hospital in New Haven, CT. At the Yale University School of Medicine, Dr. Bick completed a fellowship in Human Genetics and Pediatrics in 1986, followed by a post-doctoral research fellowship in Human Genetics in 1987. Dr. Bick is board certified in pediatrics, clinical genetics, and clinical molecular genetics.

He is a leader in the field of genomic medicine and has published numerous peer-reviewed articles, chapters, and reviews. Dr. Bick’s laboratories at the Medical College of Wisconsin and Children’s Hospital of Wisconsin were the first in the world to offer whole genome sequencing as a clinical test. He also developed the first Genomic Medicine Clinic in the United States.

Presentation(s):

Send Email for David Bick

James Lu

Co-Founder & SVP, Applied Genomics
Helix

James Lu, MD, PhD, is co-founder and SVP of Applied Genomics at Helix, a consumer genomics company that is empowering every person to discover insights into his or her own DNA through an ecosystem of high-quality content partners. At Helix, James has responsibility for the scientific teams. Prior to Helix, James was an Associate in Research at Duke University where he focused on translational genomics and developing machine learning methodologies applied to electronic medical records. James has also explored a broad range of research topics in population genetics, mendelian genomics and computational psychiatry. Earlier in his career James spent time at Merck & Co where he focused on manufacturing process optimization and Devon Park Bioventures, a Philadelphia based healthcare venture capital firm. James holds a BS and MS in Chemical Engineering from Stanford University. He received his MD and PhD from Baylor College of Medicine.

Presentation(s):

Send Email for James Lu


Assets

1D - Consumer Genomics: Direct or Indirect, Does It Really Matter?
(Attendance CEU 1.5)



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Consumer Genomics: Direct or Indirect, Does It Really Matter?
(Attendance CEU 1.5)